{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:05:49Z","timestamp":1780491949014,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.ygyno.2010.07.004","type":"journal-article","created":{"date-parts":[[2010,8,15]],"date-time":"2010-08-15T04:41:38Z","timestamp":1281847298000},"page":"237-242","source":"Crossref","is-referenced-by-count":23,"title":["Cost-effectiveness of using human papillomavirus 16\/18 genotype triage in cervical cancer screening"],"prefix":"10.1016","volume":"119","author":[{"given":"Arthi","family":"Vijayaraghavan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly B.","family":"Efrusy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karyn A.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Santas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warner K.","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2010.07.004_bb0005","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Munoz","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0010","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djn510","article-title":"Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States","volume":"101","author":"Wheeler","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0015","series-title":"American Society for Colposcopy and Cervical Pathology (ASCCP)","article-title":"HPV genotyping clinical update","author":"Anon","year":"2009"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0020","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer","volume":"357","author":"Mayrand","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0025","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/jnci\/djn444","article-title":"Efficacy of HPV DNA testing with cytology triage and\/or repeat HPV DNA testing in primary cervical cancer screening","volume":"101","author":"Naucler","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0030","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/jnci\/djn065","article-title":"Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test","volume":"100","author":"Ronco","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 10","key":"10.1016\/j.ygyno.2010.07.004_bb0035","doi-asserted-by":"crossref","first-page":"K29","DOI":"10.1016\/j.vaccine.2008.06.019","article-title":"Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries","volume":"26","author":"Cuzick","year":"2008","journal-title":"Vaccine"},{"issue":"Suppl 10","key":"10.1016\/j.ygyno.2010.07.004_bb0040","doi-asserted-by":"crossref","first-page":"K42","DOI":"10.1016\/j.vaccine.2008.05.002","article-title":"New technologies in cervical cancer screening","volume":"26","author":"Gravitt","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0045","series-title":"Cost-effectiveness in health and medicine","first-page":"425","author":"Gold","year":"1996"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0050","series-title":"Methods for the economic evaluation of health care programmes","author":"Drummond","year":"1987"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0055","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ygyno.2008.08.030","article-title":"Cost effectiveness of high-risk HPV DNA testing for cervical cancer screening in South Africa","volume":"112","author":"Vijayaraghavan","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0060","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1086\/428850","article-title":"Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica","volume":"191","author":"Herrero","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0065","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice","volume":"97","author":"Khan","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0070","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/01.AOG.0000254165.92653.e8","article-title":"Cervical cancer incidence in a prevaccine era in the United States, 1998\u20132002","volume":"109","author":"Saraiya","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.bjc.6600688","article-title":"Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis","volume":"88","author":"Clifford","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0080","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1086\/587698","article-title":"Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination","volume":"197","author":"Trottier","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0085","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/jnci\/djg037","article-title":"Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia","volume":"95","author":"Schlecht","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0090","first-page":"945","article-title":"Human papillomavirus testing for primary screening of cervical cancer precursors","volume":"9","author":"Ratnam","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0095","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and North American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0100","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/sj.bjc.6602728","article-title":"The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13,842 women","volume":"93","author":"Bigras","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3201\/eid0901.020168","article-title":"Cost effectiveness of a potential vaccine for human papillomavirus","volume":"9","author":"Sanders","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0110","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3322\/canjclin.51.2.92","article-title":"Cervical cancer: prevention, diagnosis, and therapeutics","volume":"51","author":"Janicek","year":"2001","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0115","series-title":"Staging classifications and clinical practice guidelines for gynaecological cancers","first-page":"88","author":"Pecorelli","year":"2000"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0120","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0360-3016(98)00067-4","article-title":"Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix","volume":"41","author":"Perez","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0125","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/LGT.0b013e3181585870","article-title":"2006 consensus guidelines for the management of women with abnormal cervical screening tests","volume":"11","author":"Wright","year":"2007","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0130","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/LGT.0b013e318159408b","article-title":"2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ","volume":"11","author":"Wright","year":"2007","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0135","series-title":"Macroeconomics and health: investing in health for economic development: report of the Commission on Macroeconomics and Health","year":"2001"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0140","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","article-title":"HPV screening for cervical cancer in rural India","volume":"360","author":"Sankaranarayanan","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0145","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1001\/jama.287.18.2382","article-title":"Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance","volume":"287","author":"Kim","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0150","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/01.AOG.0000120143.50098.c7","article-title":"Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30years or more","volume":"103","author":"Goldie","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0155","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/jnci\/djn019","article-title":"Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16, 18 vaccination","volume":"100","author":"Goldhaber-Fiebert","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 10","key":"10.1016\/j.ygyno.2010.07.004_bb0160","doi-asserted-by":"crossref","first-page":"K76","DOI":"10.1016\/j.vaccine.2008.06.009","article-title":"Modeling cervical cancer prevention in developed countries","volume":"26","author":"Kim","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0165","doi-asserted-by":"crossref","first-page":"83","DOI":"10.6004\/jnccn.2008.0008","article-title":"The potential utility of HPV genotyping in screening and clinical management","volume":"6","author":"Castle","year":"2008","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ygyno.2010.07.004_bb0170","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/cncr.22751","article-title":"Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing","volume":"111","author":"Schiffman","year":"2007","journal-title":"Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.ygyno.2010.07.004_bb0175","doi-asserted-by":"crossref","first-page":"A16","DOI":"10.1016\/j.vaccine.2007.11.069","article-title":"Cervical cancer screening following prophylactic human papillomavirus vaccination","volume":"26","author":"Franco","year":"2008","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ygyno.2010.07.004_bb0180","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ygyno.2010.01.037","article-title":"What is the role of HPV typing in the United States now and in the next five years in a vaccinated population?","volume":"117","author":"Huh","year":"2010","journal-title":"Gynecol Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825810005251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825810005251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T18:52:19Z","timestamp":1559415139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825810005251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0090825810005251"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2010.07.004","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}